Total submissions: 4
Submitter | RCV | SCV | Clinical significance | Condition | Last evaluated | Review status | Method | Comment |
---|---|---|---|---|---|---|---|---|
Department of Biochemistry, |
RCV001352902 | SCV001547513 | pathogenic | Syndromic intellectual disability | 2021-03-25 | criteria provided, single submitter | research | Using whole-exome sequencing, we identified the variant NM_024725.3(CCDC82): c.535C>T (p.Arg179*) (rs758691852) in two siblings with intellectual disability and spasticity. We validated the variant status in the patients using Sanger sequencing and detected it in a heterozygous status in their parents. The variant NM_024725.3(CCDC82): c.535C>T (p.Arg179*) (rs758691852) is predicted to cause premature termination of the CCDC82 protein composed of 544 amino acids. The same variant was identified previously in two patients from Middle-East with non-syndromic ID (Harripaul et al., 2018). Another variant in the CCDC82 gene (NM_024725.3(CCDC82):c.373delG (p.Asp125Ilefs*6)) was identified before in four patients from a Pakistani family, two siblings and their cousins, who manifested a core phenotype of moderate ID and delayed speech (Riazuddin et al., 2017). |
Gene |
RCV002250375 | SCV004031768 | uncertain significance | not provided | 2023-02-28 | criteria provided, single submitter | clinical testing | Nonsense variant predicted to result in protein truncation or nonsense mediated decay in a gene or region of a gene for which loss of function is not a well-established mechanism of disease; This variant is associated with the following publications: (PMID: 35118659, 28397838) |
Genomic Medicine Center of Excellence, |
RCV002250375 | SCV004806225 | likely pathogenic | not provided | 2024-03-25 | criteria provided, single submitter | clinical testing | |
OMIM | RCV002250375 | SCV002520626 | uncertain significance | not provided | 2022-05-25 | no assertion criteria provided | literature only |